Eastgate Biotech Corp. engages in the development of novel formulations of natural compounds and pharmaceutical products. It intends to accomplish by developing its proprietary self-emulsifying drug delivery systems, predominantly forming nanoemulsions. The company was founded on September 8, 1999 and is headquartered in Toronto, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company